Maryland Attorney General Anthony G. Brown today announced that Maryland and 41other states have settled antitrust litigation against the maker of Suboxone, which is a combination of the drugs buprenorphine and naloxone, used to control the effects of opioid addiction. Under the settlement, Indivior, Inc. will pay the plaintiff states $102.5 million. Maryland will receive over $2 million from the settlement. The settlement was filed in federal court in the Eastern District of Pennsylvania.
In 2016, the states filed a complaint against Indivior Inc. alleging that, in order to preserve its monopoly over the brand-name Suboxone, the company used illegal means in violation of the antitrust laws to switch the Suboxone market from tablets to film, while attempting to destroy the market for tablets.